Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction (Q43813886)

27 November 2017

0 references

Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction (English)

1 reference

multicenter clinical trial

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

author

Christopher B. Granger

9

object named as

Granger CB

1 reference

27 November 2017

6

Nartowicz E

1 reference

27 November 2017

5

Kuch J

1 reference

27 November 2017

Sadowski ZP

1

1 reference

27 November 2017

Alexander JH

2

1 reference

27 November 2017

Skrabucha B

3

1 reference

27 November 2017

Dyduszynski A

4

1 reference

27 November 2017

Swiatecka G

7

1 reference

27 November 2017

Kong DF

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

27 November 2017

published in

American Heart Journal

1 reference

27 November 2017

volume

137

1 reference

27 November 2017

issue

5

1 reference

27 November 2017

page(s)

792-798

1 reference

The coronary care unit. New perspectives and directions

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Lignocaine Therapy for Ventricular Ectopic Activity after Acute Myocardial Infarction: A Double-blind Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Lignocaine given prophylactically to patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Controlled trial of prophylatic treatment with lidocaine in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Antiarrhythmic efficacy and side-effects of lidocaine given in the prehospital phase of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Prophylactic lidocaine in the early phase of suspected myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Prophylactic lidocaine in the prehospital patient with chest pain of suspected cardiac origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970401-1

10.1016/S0002-8703(99)70401-1

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference